Furthermore, inhibitors of glutaminase, an enzyme that breaks down glutamine, renders VHL-deficient RCC cells sensitive to glutamine depletion in vitro, blocking tumor xenograft growth in mice. The gene discussed is VHL; the disease is renal cell carcinoma.